Robert Wolfe - Advanced Oxygen Chairman of the Board, CEO, CFO
AOXY Stock | USD 0.06 0.00 0.00% |
Chairman
Mr. Robert E. Wolfe is Chairman of the Board, Chief Executive Officer and Chief Financial Officer of Advanced Oxygen Technologies, Inc. He was the Chairman and CEO for Advanced Oxygen Technologies Inc. since 1997. Concurrently he was the President and CEO of Crossfield, Inc. and Crossfield Investments, llc, both corporate consulting companies. From 19921993 he was Vice President and partner for CFI, NY Ltd. A Subsidiary of Corporationrationrate Financial Investments, PLC, London. since 1997.
Age | 60 |
Tenure | 27 years |
Phone | 212 727 7085 |
Web | https://www.aoxy-ca.com |
Robert Wolfe Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Wolfe against Advanced Oxygen pink sheet is an integral part of due diligence when investing in Advanced Oxygen. Robert Wolfe insider activity provides valuable insight into whether Advanced Oxygen is net buyers or sellers over its current business cycle. Note, Advanced Oxygen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Advanced Oxygen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Wolfe over a year ago Chart Industries exotic insider transaction detected |
Advanced Oxygen Management Efficiency
The company has return on total asset (ROA) of 0.0105 % which means that it generated a profit of $0.0105 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.182 %, meaning that it created $0.182 on every $100 dollars invested by stockholders. Advanced Oxygen's management efficiency ratios could be used to measure how well Advanced Oxygen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 3 records | CHAIRMAN Age | ||
David Devilliers | Frp Holdings Ord | 73 | |
Warren Haruki | Maui Land Pineapple | 71 | |
CPA II | Frp Holdings Ord | 75 |
Management Performance
Return On Equity | 0.18 | |||
Return On Asset | 0.0105 |
Advanced Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Advanced Oxygen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.18 | |||
Return On Asset | 0.0105 | |||
Profit Margin | 1.44 % | |||
Operating Margin | 0.28 % | |||
Current Valuation | 822.28 K | |||
Shares Outstanding | 3.29 M | |||
Shares Owned By Insiders | 66.96 % | |||
Price To Earning | 77.33 X | |||
Price To Book | 2.74 X | |||
Price To Sales | 19.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Oxygen's price analysis, check to measure Advanced Oxygen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Oxygen is operating at the current time. Most of Advanced Oxygen's value examination focuses on studying past and present price action to predict the probability of Advanced Oxygen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Oxygen's price. Additionally, you may evaluate how the addition of Advanced Oxygen to your portfolios can decrease your overall portfolio volatility.